Cited by 48Renin-Angiotensin System StudiesNitric Oxide and Endothelin EffectsEicosanoids and Hypertension Pharmacology

The Central Effects of a Nitric Oxide Synthase Inhibitor (Nω- Nitro - L - Arginine) on Blood Pressure and Plasma Renin

El karib, Abbas O., Sheng, Jiangjun, Betz, A. Lorris, Malvin, Richard L.·1993·Clinical and Experimental Hypertension

Abstract

An endothelium-derived relaxing factor has been identified as nitric oxide (NO). Peripheral and central administration of nitric oxide synthase inhibitors result in an increase in renal sympathetic nerve activity and an increase in blood pressure. The goal of our study was to determine if the increase in blood pressure following central NO synthase inhibition with N omega-nitro-L-arginine (L-NNA) is caused by the release of renin. Six groups of Sprague-Dawley rats were used. Group I (control) received intracerebroventricular (i.c.v.) artificial cerebrospinal fluid. Groups II & III received i.c.v. L-NNA, 5 & 15 micrograms/min. respectively. Group IV was treated with intravenous L-NNA, 15 micrograms/min. Group V, after bilateral nephrectomy, received i.c.v. L-NNA, 15 micrograms/min. Group VI received i.c.v. L-arginine, 60 micrograms/min. and i.c.v. L-NNA, 15 micrograms/min., simultaneously. Plasma renin concentration was measured in groups I, III, IV & V. Mean arterial blood pressure was significantly increased in groups II, III & V, i.e., following i.c.v. infusion of L-NNA. The increase in mean arterial blood pressure was significantly greater when the dose was increased from 5 to 15 micrograms/min. and it was eliminated when L-arginine was added to the infusion. The increase in blood pressure was attended by no change in heart rate. While the plasma renin concentration increased significantly in group III, this could not explain the increase in blood pressure since the nephrectomized group (V) showed no increase in renin concentration but an equivalent increase in blood pressure. The results show that acute central administration of a low dose of L-NNA increases blood pressure in rats and this increase can be prevented by central administration of L-arginine. However, intravenous infusion of the same dose (15 micrograms/min.) of L-NNA does not change blood pressure. We conclude that L-NNA acts directly within the central nervous system to increase blood pressure by a renin-independent mechanism. These results imply that central nitric oxide plays an important role in the regulation of blood pressure.

Integrity signals

Registry

Crossref · 10.3109/10641969309041644

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NOS1 activity in the medulla and hypothalamus is important for systemic regulation of blood pressure.

    “NOS1 activity in the medulla and hypothalamus is important for systemic regulation of blood pressure [104-107]”

    From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [106]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
El karib, A. O., Sheng, J., Betz, A. L., & Malvin, R. L.
Affiliations
University of Michigan (US)
Venue
Clinical and Experimental Hypertension
Published
1993-01
Volume
15
Issue
5
Pages
819-832
ISSN
  • 0148-3927 (ISSN-L)
  • 1064-1963
  • 1525-6006
OpenAlex
W2122696877
Cited by
48
References
29
Citations by year
2026: 1 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
2.30
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (P01HL018575, HL 18575)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
nitric oxide synthase inhibition, L-NNA, nitric oxide, central nervous system, blood pressure regulation, plasma renin, L-arginine, renal sympathetic nerve activity, intracerebroventricular administration, bilateral nephrectomy
MeSH terms
Amino Acid Oxidoreductases, Animals, Arginine, Blood Pressure, Injections, Intravenous, Injections, Intraventricular, Kidney, Male, Nephrectomy, Renin, Sympathetic Nervous System, Rats, Sprague-Dawley, Nitric Oxide Synthase, Nitroarginine, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review